The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A new modified sunitinib schedule for metastatic renal cell cancer (mRCC): A pilot study.
Sebastiano Buti
No relevant relationships to disclose
Maddalena Donini
No relevant relationships to disclose
Silvia Lazzarelli
No relevant relationships to disclose
Matteo Brighenti
No relevant relationships to disclose
Rodolfo Passalacqua
No relevant relationships to disclose